ONE LIVER, THREE RECIPIENTS: SEGMENT IV FROM SPLIT-LIVER PROCEDURES AS A SOURCE OF HEPATOCYTES FOR CELL TRANSPLANTATION
- 27 May 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 77 (10) , 1614-1616
- https://doi.org/10.1097/01.tp.0000122224.98318.19
Abstract
Hepatocyte transplantation is emerging as a possible treatment for patients with acute liver failure and liver-based metabolic disorders. With the limited availability of donor tissue, it is important to find new sources of liver tissue for isolation of high-quality hepatocytes. Segment IV with or without the caudate lobe was removed during three split-liver procedures. Hepatocytes were isolated from the tissues using a collagenase perfusion technique under strict sterile conditions. The mean number of hepatocytes that were isolated was 5.14×108 cells with a mean cell viability of 89%. Two of the hepatocyte preparations were used for cell transplantation in a 1-day-old boy with an antenatal diagnosis of a severe urea cycle defect caused by ornithine transcarbamylase deficiency. The six recipients of split-liver grafts demonstrated no complications related to the removal of segment IV. Segment IV with or without the caudate lobe obtained from split-liver procedures is potentially a good source of high-quality hepatocytes for cell transplantation.Keywords
This publication has 9 references indexed in Scilit:
- Isolated Hepatocyte Transplantation in an Infant With a Severe Urea Cycle DisorderPediatrics, 2003
- Human hepatocyte isolation and relationship of cell viability to early graft function.Cell Transplantation, 2003
- Hepatocyte transplantation as a treatment for glycogen storage disease type 1aThe Lancet, 2002
- Hepatocyte transplantation in acute liver failureLiver Transplantation, 2000
- Hepatocyte transplantation in acute liver failureLiver Transplantation, 2000
- CRYOPRESERVED PRIMARY HEPATOCYTES AS A CONSTANTLY AVAILABLE IN VITRO MODEL FOR THE EVALUATION OF HUMAN AND ANIMAL DRUG METABOLISM AND ENZYME INDUCTION*Drug Metabolism Reviews, 2000
- Treatment of the Crigler–Najjar Syndrome Type I with Hepatocyte TransplantationNew England Journal of Medicine, 1998
- Split Liver TransplantationAnnals of Surgery, 1998
- HEPATOCYTE TRANSPLANTATION AS A BRIDGE TO ORTHOTOPIC LIVER TRANSPLANTATION IN TERMINAL LIVER FAILURETransplantation, 1997